AB-04

N/A

Report date: 2025/01/26 15:58:26

Base Information

Drug NameAB-04
Drug Alias NameAB-569 (Arch Biopartners)live biotherapeutic product consortia for type 2 diabetes (AsiaBiome)AB-04
ClassificationBiologics
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsiaBiome
China Registration ClassN/A

Develop Information

Active CompaniesAsiaBiome
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A